48.05
price down icon0.06%   -0.01
 
loading
Qiagen Nv stock is traded at $48.05, with a volume of 508.94K. It is down -0.06% in the last 24 hours and up +6.43% over the past month. Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
See More
Previous Close:
$48.06
Open:
$47.88
24h Volume:
508.94K
Relative Volume:
0.37
Market Cap:
$10.01B
Revenue:
$1.98B
Net Income/Loss:
$83.59M
P/E Ratio:
128.48
EPS:
0.374
Net Cash Flow:
$502.31M
1W Performance:
+1.69%
1M Performance:
+6.43%
6M Performance:
+4.86%
1Y Performance:
+16.07%
1-Day Range:
Value
$47.77
$48.82
1-Week Range:
Value
$46.37
$48.82
52-Week Range:
Value
$37.74
$49.30

Qiagen Nv Stock (QGEN) Company Profile

Name
Name
Qiagen Nv
Name
Phone
-
Name
Address
-
Name
Employee
5,700
Name
Twitter
@QIAGEN
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
QGEN's Discussions on Twitter

Compare QGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
QGEN
Qiagen Nv
48.04 10.01B 1.98B 83.59M 502.31M 0.374
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
418.87 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
200.38 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
541.50 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.26 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
162.54 27.64B 15.50B 1.33B 2.16B 7.34

Qiagen Nv Stock (QGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-04-25 Downgrade Redburn Atlantic Buy → Neutral
Feb-19-25 Downgrade Robert W. Baird Outperform → Neutral
Jan-06-25 Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-10-24 Upgrade Jefferies Hold → Buy
Oct-17-24 Downgrade HSBC Securities Buy → Hold
Jun-27-24 Upgrade Wolfe Research Peer Perform → Outperform
Dec-19-23 Initiated Wells Fargo Equal Weight
Dec-13-23 Initiated Wolfe Research Peer Perform
Dec-07-23 Upgrade Goldman Neutral → Buy
Sep-12-23 Initiated Robert W. Baird Outperform
May-23-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-18-22 Initiated Morgan Stanley Equal-Weight
Jan-18-22 Upgrade DZ Bank Hold → Buy
Oct-15-21 Resumed Cowen Market Perform
Oct-14-21 Initiated Redburn Buy
Jul-14-21 Downgrade Kepler Buy → Hold
Jun-03-21 Initiated Goldman Neutral
Oct-06-20 Resumed BofA Securities Buy
Sep-28-20 Upgrade Kepler Hold → Buy
Aug-24-20 Upgrade Citigroup Neutral → Buy
Aug-20-20 Resumed JP Morgan Overweight
Aug-17-20 Upgrade Berenberg Hold → Buy
Aug-14-20 Upgrade Deutsche Bank Hold → Buy
Aug-14-20 Upgrade Exane BNP Paribas Neutral → Outperform
Mar-04-20 Downgrade Berenberg Buy → Hold
Jan-08-20 Initiated Wells Fargo Equal Weight
Jan-07-20 Initiated Citigroup Neutral
Dec-26-19 Resumed BofA/Merrill Underperform
Nov-15-19 Initiated Stifel Hold
Nov-14-19 Upgrade Evercore ISI In-line → Outperform
Nov-14-19 Upgrade JP Morgan Underweight → Overweight
Nov-14-19 Upgrade Kepler Reduce → Hold
Oct-17-19 Upgrade Wolfe Research Peer Perform → Outperform
Oct-09-19 Downgrade Kepler Hold → Reduce
Oct-08-19 Downgrade Barclays Overweight → Equal Weight
Oct-08-19 Downgrade Deutsche Bank Buy → Hold
Oct-08-19 Downgrade JP Morgan Neutral → Underweight
View All

Qiagen Nv Stock (QGEN) Latest News

pulisher
Jun 19, 2025

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership - BioSpace

Jun 19, 2025
pulisher
Jun 18, 2025

Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen and Gencurix partner for oncology tests - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen’s Voting Rights Notification Highlights BlackRock’s Influence - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

BlackRock’s Significant Stake in Qiagen Revealed - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen (QGEN) Partners with Gencurix to Enhance Oncology Diagnos - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen, Gencurix Launch Oncology Testing Development Partnership - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen and Gencurix partner for oncology tests (QGEN:NYSE) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

QIAGEN, GENCURIX announce QIAcuity Digital PCR IVD Assay Development Partnership - marketscreener.com

Jun 18, 2025
pulisher
Jun 17, 2025

QGEN Stock Rises in After Market Following Partnership With Incyte - MSN

Jun 17, 2025
pulisher
Jun 17, 2025

Qiagen and Incyte announce precision medicine collaboration - BioSpectrum Asia

Jun 17, 2025
pulisher
Jun 16, 2025

Should You Add QIAGEN Stock to Your Portfolio for Now? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms - Medical Device Network

Jun 16, 2025
pulisher
Jun 16, 2025

QIAGEN, Incyte Partner to Develop NGS-Based Diagnostic Panel for Rare Blood Cancers - MarketScreener

Jun 16, 2025
pulisher
Jun 15, 2025

QIAGEN And Incyte Partner To Create New Test For Rare Blood Cancers - Nasdaq

Jun 15, 2025
pulisher
Jun 15, 2025

QIAGEN and Incyte Announce Precision Medicine Collaboration to D - GuruFocus

Jun 15, 2025
pulisher
Jun 15, 2025

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) | QGEN Stock News - GuruFocus

Jun 15, 2025
pulisher
Jun 15, 2025

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) - Yahoo Finance

Jun 15, 2025
pulisher
Jun 14, 2025

QIAGEN expands portfolio for MRD testing in oncology with two partnerships - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

Qiagen Announces Significant Shareholding Notification - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 10, 2025

Qiagen Reports Change in Voting Rights Held by BlackRock - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

Qiagen Announces Voting Rights Notification by AFM - TipRanks

Jun 10, 2025
pulisher
Jun 09, 2025

Here's Why Qiagen (QGEN) is a Strong Momentum Stock - Yahoo Finance

Jun 09, 2025
pulisher
Jun 08, 2025

Qiagen (NYSE:QGEN) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

QIAGEN (QGEN) Partners with Tracer Biotechnologies for MRD Assays - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 06, 2025
pulisher
Jun 06, 2025

QGEN Partners with Tracer Biotechnologies to Advance Cancer Test - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Qiagen (NYSE:QGEN) Sees Large Increase in Short Interest - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid Tumors - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

QGEN Partners with Tracer Biotechnologies to Advance Cancer Testing | QGEN Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Qiagen, Tracer Biotechnologies announce strategic partnership - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Transcript : Qiagen N.V. Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 09 - MarketScreener

Jun 05, 2025
pulisher
Jun 04, 2025

Qiagen N.V. Reports Significant Voting Rights Held by BlackRock - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Forensic Genomics Market Research 2025Global Trends, Opportunity, and Forecasts 2020-2030 - GlobeNewswire Inc.

Jun 04, 2025
pulisher
Jun 04, 2025

Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

QIAGEN NV : Receives a Buy rating from Deutsche Bank - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Qiagen expands portfolio for minimal residual disease testing in oncology - BioSpectrum Asia

Jun 03, 2025
pulisher
Jun 02, 2025

Foresight Diagnostics and Qiagen Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Qiagen Enters Partnerships, Expands Portfolio for Minimal Residual Disease Testing in Oncology - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships - Business Wire

Jun 02, 2025
pulisher
Jun 02, 2025

Foresight Diagnostics And Qiagen Announce Strategic Partnership To Advance Development Of Companion Diagnostic Kits For Lymphoma - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Qiagen (QGEN) Forms Strategic Alliance with Foresight Diagnostic - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Qiagen (QGEN) Forms Strategic Alliance with Foresight Diagnostics | QGEN Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma - marketscreener.com

Jun 02, 2025

Qiagen Nv Stock (QGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$178.63
price down icon 0.56%
diagnostics_research WAT
$356.76
price up icon 2.20%
diagnostics_research LH
$263.00
price up icon 0.11%
$162.09
price down icon 3.89%
diagnostics_research MTD
$1,205.58
price up icon 2.42%
diagnostics_research IQV
$162.51
price up icon 3.06%
Cap:     |  Volume (24h):